ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,469Medicare Part D Prescriptions Filled, Including Refills

Rank: 380 out of 890

$341K Total Retail Price of All Prescriptions

Rank: 386 out of 890

139 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 139 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 5,438 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

47 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 228 189 1 2
GLIMEPIRIDE 156 124 2 27
GABAPENTIN 154 128 3 12
AMLODIPINE BESYLATE 145 128 4 1
LOSARTAN-HYDROCHLOROTHIAZIDE 143 140 5 57
POTASSIUM CHLORIDE 130 110 6 11
SIMVASTATIN 128 118 7 5
FUROSEMIDE 127 88 8 7
CLONIDINE HCL 123 119 9 35
METFORMIN HCL 110 84 10 6
METOPROLOL SUCCINATE 106 94 11 17
LOSARTAN POTASSIUM 105 91 12 29
MELOXICAM 105 95 12 18
PRAVASTATIN SODIUM 98 85 14 10
TRAMADOL HCL 94 92 15 16
RANITIDINE HCL 94 94 15 49
NEXIUM 89 43 17 14
METFORMIN HCL ER 86 59 18 54
PREDNISONE 85 71 19 47
OMEPRAZOLE 85 62 19 8
NAPROXEN 79 73 21 84
HYDROCHLOROTHIAZIDE 78 73 22 9
SINGULAIR 77 46 23 79
ATORVASTATIN CALCIUM 73 73 24 13
ZOLPIDEM TARTRATE 72 71 25 19
GLIPIZIDE ER 71 59 26 110
LANTUS 69 69 27 50
CELEBREX 68 56 28 91
LYRICA 68 47 28 71
NIFEDIPINE ER 65 48 30 75
DOXEPIN HCL 62 61 31 176
DIGOXIN 60 51 32 65
CLOPIDOGREL 59 59 33 28
METOPROLOL TARTRATE 56 44 34 15
HYDROCODONE-ACETAMINOPHEN 53 47 S3 35 3
LISINOPRIL 52 34 36 4
CITALOPRAM HBR 51 51 37 20
ISOSORBIDE MONONITRATE 50 50 38 346
DIOVAN 50 42 38 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 17, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.